Alnylam Pharmaceuticals, Inc. (ALNY) – Medical Equipment – Deals and Alliances Profile

Date: 2015-06
Pages:56
Price:

“Alnylam Pharmaceuticals, Inc., (Alnylam) is a biopharmaceutical company. It focuses on the discovery, development and commercialization of novel therapeutics based on Ribo Nucleic Acid interference (RNAi). The company is primarily involved in its Alnylam 5×15 program for developing RNAi based therapeutics targeted against genetically defined diseases. Alnylam鈥檚 pipeline products in various clinical development stages include Patisiran (ALN-TTR02) for the treatment of transthyretin-mediated amyloidosis (ATTR); ALN-TTRsc for the treatment of ATTR in patients with TTR cardiac amyloidosis; ALN-AT3 for the treatment of for the treatment of hemophilia and rare bleeding disorders; ALN-CC5 for the treatment of complement-mediated diseases; ALN-AS1 for the treatment of hepatic porphyrias; ALN-PCSsc for the treatment of hypercholesterolemia; ALN-AAT for the treatment of AAT deficiency liver disease; ALN-TMP for the treatment of beta-thalassemia and iron-overload disorders; and ALN-ANG for the treatment of genetic forms of mixed hyperlipidemia and severe hypertriglyceridemia. The company has a Biotherapeutics division, Alnylam Biotherapeutics, which focuses on development of RNAi technologies such as VaxiRNA technology with applications in vaccine and other biologics manufacturing processes. The company has various platform, discovery and development, and product alliances with various companies that include Medtronic; Novartis Pharma AG; Biogen Idec; Roche Ltd., Takeda Pharmaceutical Company; Kyowa Hakko Kirin; Cubist Pharmaceuticals; Genzyme and Isis among others. Alnylam is headquartered in Cambridge, Massachusetts, the US.

Alnylam Pharmaceuticals, Inc. (ALNY) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

– Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
– Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
– Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
– Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
– Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
– Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company鈥檚 (major public companies) key financial metrics and ratios.
– Business Description – A brief description of the company’s operations.
– Key Employees – A list of the key executives of the company.
– Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
– Key Competitors – A list of the key competitors of the company.
– Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
– The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
– The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
– Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company鈥檚 operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
– Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
– Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.”

Categories

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample